GeoVax Labs, Inc. (GOVX) Form S-1 — Nov 3, 2026
GeoVax Labs filed an S-1 for a firm commitment public offering of 29,585,798 shares at an assumed $0.169 per share, plus pre-funded warrants for up to the same number of shares, targeting roughly $5.0 million gross and $4.6 million net proceeds with E.F. Hutton as sole underwriter. The share count would balloon from 12.2 million to 41.8 million shares (46.2 million with the greenshoe) — dilution exceeding 240% of the pre-offering share base. The offering is effectively a survival raise.
Key figures
- Cash Position
- 3143422
- Gross Proceeds
- 5000000
- Offering Price
- 0.169
- Shares Offered
- 29585798
- Shares Outstanding
- 12209871
- Net loss fy2025
- 21500000
- Net loss h1 2026
- 9700000
- Pre funded warrants
- up to 29,585,798 at $0.001 exercise
- Over allotment shares
- 4437869
- Net proceeds estimated
- 4628000
- Revolving loan capacity
- 1000000
- Revolving loan rate pct
- 12
- Shares outstanding after
- 41795669
- August 2026 warrant price
- 0.64
- Underwriting discount pct
- 4
- August 2026 warrant shares
- 11395256
- Stockholders equity 6 30 26
- 1760701
- Proposed reverse split ratio
- 1-for-10 to 1-for-25
- Shares outstanding after greenshoe
- 46233538
AI analysis
Red flags9 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.